Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Nov 2, 2023Virtual Press Office and PR Newswire: General Trade show news
Preparing organizations for the next trust frontier through knowledge and cutting-edge AI Governance solutions BOSTON, Nov. 2, 2023 /PRNewswire/ -- IAPP AI Governance Global 2023 -- OneTrust, the...
-
Nov 2, 2023Virtual Press Office and PR Newswire: General Trade show news
-- Growing body of data on REZLIDHIA® (olutasidenib) in mIDH1 relapsed or refractory (R/R) acute myeloid leukemia (AML) patients -- -- New data on olutasidenib in patients with mIDH1...
-
Nov 2, 2023Virtual Press Office and PR Newswire: General Trade show news
Lishan Aklog, M.D., Chairman & CEO, to Present November 16, 2023, in New York NEW YORK, Nov. 2, 2023 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a...
-
Nov 2, 2023Virtual Press Office and PR Newswire: General Trade show news
Auxora™ showed a 53% reduction in days in hospital, a 40% reduction in intensive care unit (ICU) days and eliminated the need for total parenteral nutrition (TPN) LA JOLLA, Calif., Nov. 2, 2023...
-
Nov 2, 2023Virtual Press Office and PR Newswire: General Trade show news
Amanda Seyfried on Banned Books, Ilana Glazer and Dr. Ayana Elizabeth Johnson on Climate, Allie Phillips on Abortion Bans, and More Among Speakers at 2nd Annual Summit NEW YORK, Nov. 2, 2023...
-
Nov 2, 2023LA Auto Show - show news releases and content
Subaru of America, Inc. today announced an all-new fully redesigned vehicle will make its global debut at 9:40 a.m. PT (12:40 p.m. ET) on November 16 at the 2023 Los Angeles Auto Show. Please...
-
Nov 2, 2023Virtual Press Office and PR Newswire: General Trade show news
– Additional data from pivotal AUGMENT-101 trial in R/R KMT2Ar acute leukemia further highlight revumenib's potential best-in-class profile – – 100% ORR (n=7) and manageable safety profile...
-
Nov 2, 2023Virtual Press Office and PR Newswire: General Trade show news
Oral presentation will showcase distinct preclinical profile for potent, selective MALT1 scaffolding inhibitor that is highly differentiated from MALT1 protease inhibitors BOSTON, Nov. 2, 2023...
-
Nov 2, 2023Virtual Press Office and PR Newswire: General Trade show news
– Results support axatilimab's promising safety and efficacy profile, and reinforce its potential as a first-in-class CSF-1R monoclonal antibody in chronic graft-versus-host disease – –...
-
Nov 2, 2023Virtual Press Office and PR Newswire: General Trade show news
Program participants have exclusive access to the RO element before commercial launch and receive special pricing incentives. BOSTON, Nov. 2, 2023 /PRNewswire/ -- ZwitterCo, the advanced membrane...